急性丙型肝炎

HCVⅡ/Ⅲ混合型1例，为急性丙型肝炎。

Case of genotype ⅱ / ⅲ mixed was as acute hepatitis .

急性丙型肝炎患者NK细胞活性和T细胞亚群研究

Study of NK Activity and T-cell Subsets in Acute Hepatitis C Patients

方法IFNα-2b3Mu皮下注射，隔天1次，6个月一疗程，治疗急性丙型肝炎24例，阳性丙型肝炎38例，治疗后随访2～4年。

Methods 24 cases of acute hepatitis C patients and 38 cases of chronic hepatitis C patients received 3 MU interferon α - 2b subcutaneously every two days for 6 months , and they were followed up for 2 ~ 4 years .

急性丙型肝炎基因分型的临床分析

The clinical analysis of HCV genotypes in acute hepatitis C

急性丙型肝炎病理学观察

Pathological Changes in Cases of Acute Hepatitis C

所确诊的急性丙型肝炎均急性起病和近期有明确血制品使用史。

Every patients diagnosed as acute hepatitis had blood transfusion history and presented as acute onset .

人类急性丙型肝炎纵向研究中对CD8+T细胞反应的全面分析

Comprehensive analyses of CD8 + T cell responses during longitudinal study of acute human hepatitis C

结果北京市急性丙型肝炎报告年平均发病率为1／10万左右。

Results The annual average incidence rate of the acute Hepatitis C in Beijing was1 per100 thousands .

急性丙型肝炎一般没有病症，但是发展为慢性肝炎的为数不少。

Acute infection often goes unnoticed . A majority of acutely infected hepatitis C patients go on to develop chronic diseases .

自发性病毒清除失败后，单用聚乙二醇干扰素α-2b治疗急性丙型肝炎患者24周的疗效

Efficacy of a 24 - week course of PEG-inter-feron α - 2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance

急性丙型肝炎的发病是已分型肝炎中最低的，10年共发病25例，每年发病率均低于1/10万。

The acute HCV incidence rate was the lowest in classified hepatitis , there were 25 cases in 10 years and annual incidence rate was always lowered than 1 per 100,000 .

CD8~+T细胞亚群百分比的增加，可能与急性丙型肝炎患者的肝细胞损伤及发病机制有关。

Than in healthy controls . The results indicate that NK activity , CD8 + T-cell subset and CD4 / CD8 ratio in patients with acute hepatitis C were relationship with the hepatocellular injury in patients with acute hepatitis C.

干扰素α-2b治疗急性和慢性丙型肝炎疗效分析

Efficacy of interferon α - 2b in the treatment of acute and chronic hepatitis C